AJJ Medtech Wins S$3 Million Biodegradable Medical Consumables Contract in Singapore

AJJ Medtech Holdings Limited ( (SG:584) ) has shared an update.

AJJ Medtech Holdings’ subsidiary AJJ Healthcare Management has secured a long-term contract worth about S$3 million to supply biodegradable medical consumables to a network of Singapore healthcare institutions. The two-year deal, starting June 1, 2026 and extendable by another two years, underpins the Group’s strategy to expand its sustainable healthcare offerings and strengthens its role as a supply partner in the national healthcare ecosystem.

The latest award adds to a series of institutional contracts, bringing AJJ’s total contracted institutional revenue pipeline to over S$8 million to be recognized over three to five years. While not materially affecting current-year net tangible assets or earnings per share, the contract is expected to provide recurring revenue visibility, broaden the institutional customer base, and contribute positively to financial performance, while also avoiding over 600 tonnes of CO₂ emissions annually according to the Group’s internal estimates.

More about AJJ Medtech Holdings Limited

AJJ Medtech Holdings Limited is a Singapore-incorporated company operating in the healthcare sector through its wholly owned subsidiary AJJ Healthcare Management. The Group focuses on supplying medical and laboratory consumables, with a growing emphasis on sustainable and biodegradable products for institutional healthcare and academic customers in Singapore.

Average Trading Volume: 11,328,878

Technical Sentiment Signal: Sell

Current Market Cap: S$11.98M

See more data about 584 stock on TipRanks’ Stock Analysis page.